Sentinel node biopsy in gynaecological cancers: state of art and future perspectives

IF 2.3 4区医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Clinical and Translational Imaging Pub Date : 2024-03-04 DOI:10.1007/s40336-024-00619-2

{"title":"Sentinel node biopsy in gynaecological cancers: state of art and future perspectives","authors":"","doi":"10.1007/s40336-024-00619-2","DOIUrl":null,"url":null,"abstract":"<h3>Abstract</h3> <span> <h3>Purpose</h3> <p>This review aims to provide an overview of current knowledge and future perspectives on sentinel node biopsy in gynaecological cancers.</p> </span> <span> <h3>Methods</h3> <p>Literature research in the PubMed/MEDLINE database was carried out to identify relevant studies on sentinel node biopsy in gynaecological cancers. We selected only original studies, published in the English language and including a minimum of nine patients.</p> </span> <span> <h3>Results</h3> <p>The most relevant results on sentinel node biopsy in gynaecological cancers were summed up, focusing on clinical indications, technical aspects, preoperative and intraoperative procedures and the latest technological advances.</p> </span> <span> <h3>Conclusion</h3> <p>Sentinel node biopsy has been widely validated in well-selected patients with early-stage vulvar, cervical and endometrial cancers. It is essential to standardise the acquisition protocol, including SPECT/CT imaging, for an improved surgical planning and a personalised approach. Recent technological advances, such as hybrid tracers and intraoperative tools, may efficiently guide gynaecological cancer surgery.</p> </span>","PeriodicalId":48600,"journal":{"name":"Clinical and Translational Imaging","volume":"28 1","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40336-024-00619-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose

This review aims to provide an overview of current knowledge and future perspectives on sentinel node biopsy in gynaecological cancers.

Methods

Literature research in the PubMed/MEDLINE database was carried out to identify relevant studies on sentinel node biopsy in gynaecological cancers. We selected only original studies, published in the English language and including a minimum of nine patients.

Results

The most relevant results on sentinel node biopsy in gynaecological cancers were summed up, focusing on clinical indications, technical aspects, preoperative and intraoperative procedures and the latest technological advances.

Conclusion

Sentinel node biopsy has been widely validated in well-selected patients with early-stage vulvar, cervical and endometrial cancers. It is essential to standardise the acquisition protocol, including SPECT/CT imaging, for an improved surgical planning and a personalised approach. Recent technological advances, such as hybrid tracers and intraoperative tools, may efficiently guide gynaecological cancer surgery.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

妇科癌症的前哨节点活检：技术现状与未来展望

摘要目的本综述旨在概述有关妇科癌症前哨节点活检的现有知识和未来展望。方法在 PubMed/MEDLINE 数据库中进行文献研究，以确定有关妇科癌症前哨节点活检的相关研究。我们仅选取了以英语发表且至少包含九名患者的原创研究。结果总结了与妇科癌症前哨节点活检最相关的结果，重点关注临床适应症、技术方面、术前和术中程序以及最新技术进展。结论在经过精心挑选的早期外阴癌、宫颈癌和子宫内膜癌患者中，前哨节点活检已得到广泛验证。为了改进手术计划和采用个性化方法，必须将包括 SPECT/CT 成像在内的采集方案标准化。最近的技术进步，如混合示踪剂和术中工具，可以有效地指导妇科癌症手术。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical and Translational Imaging Medicine-Radiology, Nuclear Medicine and Imaging

CiteScore

3.60

自引率

4.80%

发文量

期刊介绍： Clinical and Translational Imaging is an international journal that publishes timely, up-to-date summaries on clinical practice and translational research and clinical applications of approved and experimental radiopharmaceuticals for diagnostic and therapeutic purposes. Coverage includes such topics as advanced preclinical evidence in the fields of physics, dosimetry, radiation biology and radiopharmacy with relevance to applications in human subjects. The journal benefits a readership of nuclear medicine practitioners and allied professionals involved in molecular imaging and therapy.